US Food Allergen Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The united states food allergen testing market size in 2026 is estimated at USD 333.63 million, growing from 2025 value of USD 315.4 million with 2031 projections showing USD 441.86 million, growing at 5.78% CAGR over 2026-2031. This report is Segmented by Allergen Type/Source (Peanuts, Tree Nuts, and More), Technology (Immunoassay/ELISA, PCR, Lateral-Flow & Biosensors, and More), Food Tested (Dairy Products, Bakery and Confectionery, and More), Testing Kits (Lab Testing, and Testing Kits), and Geography (Northeast, Midwest, South, and West). The Market Forecasts are Provided in Terms of Value (USD).

US Food Allergen Testing Market Trends and Insights

Increasing Incidence of Food Allergies in the United States

The increasing incidence of food allergies in the United States is a major driver for the growth of the food allergen testing market. As more consumers become aware of severe allergic reactions, including anaphylaxis, there is heightened demand for transparency and safety in food production. This has prompted food manufacturers to implement comprehensive allergen testing to prevent cross-contamination and protect brand reputation. Regulatory bodies like the FDA have also tightened labeling and compliance requirements, making allergen testing a critical step in meeting safety standards. Additionally, the surge in popularity of “free-from” foods - such as gluten-free, nut-free, and dairy-free products - has created a need for accurate verification through testing. Retailers and foodservice providers increasingly require documentation of allergen controls from suppliers to protect sensitive consumers. Technological advancements in testing methods, such as PCR and ELISA, have also made allergen detection faster and more reliable, further supporting market growth. Overall, rising allergy prevalence is reshaping industry practices, placing allergen testing at the core of food safety strategies.

Stringent Food Safety Regulations

The FASTER Act's designation of sesame as the ninth major allergen triggered comprehensive labeling and testing requirement updates across the food industry, with compliance enforcement intensifying throughout 2024. The FDA's warning letter to Bimbo Bakeries in June 2024 for allergen mislabeling demonstrates the agency's aggressive enforcement posture, signaling heightened compliance risks for manufacturers. The USDA's expanded Allergen Verification Sampling Program, effective September 2024, now covers 14 allergens including the 'Big 9' for ready-to-eat products, substantially broadening testing requirements. State-level variations in enforcement create compliance complexity, particularly for multi-state food processors who must navigate differing interpretation standards and inspection frequencies. The FDA's Laboratory Accreditation for Analyses of Foods program establishes mandatory third-party testing requirements for specific import scenarios, driving demand for accredited testing services. Regulatory uncertainty around emerging allergens beyond the major nine creates strategic testing challenges, as manufacturers must balance comprehensive protection against cost optimization in an evolving regulatory landscape.

High Cost of Advanced Testing Technologies

Advanced testing equipment, including LC-MS/HPLC-MS systems and next-generation sequencing platforms, requires capital huge investments, creating barriers for smaller food processors and regional testing laboratories. The Bureau of Labor Statistics reports median wages of USD 28.79 per hour for testing laboratory personnel, with specialized technicians commanding premium salaries that compound operational cost pressures. FARRP's (Food Allergy Research and Resource Program) testing services range from USD 55 to USD 205 per allergen test, with rush processing commanding additional premiums, illustrating the cost sensitivity that drives many manufacturers toward less comprehensive testing protocols. Maintenance and calibration costs for sophisticated testing equipment can go high, creating ongoing financial pressure that may discourage technology upgrades. The geographic concentration of advanced testing capabilities in major metropolitan areas creates logistical costs and time delays for manufacturers in rural regions, particularly affecting agricultural processors with seasonal testing demands.

Other drivers and restraints analyzed in the detailed report include:

• Technological Advancements in Testing Methods
• Growing Consumer Awareness and Demand for Transparency
• Lack of Standardized Testing Protocols Across Facilities

Segment Analysis

Milk allergens command the largest market share at 25.10% in 2025, reflecting their ubiquity in processed foods and the complexity of dairy-derived ingredients that require comprehensive testing across multiple protein fractions. The sesame allergen segment demonstrates the fastest growth at 7.84% CAGR through 2031, driven by the FASTER Act's January 2023 implementation that mandated sesame labeling as the ninth major allergen according to FDA (Food and Drug Administration). Tree nuts maintain significant testing demand due to cross-contamination risks in shared processing facilities, while peanut testing remains critical given the severity of allergic reactions and legal liability concerns. Egg allergens present unique challenges in processed foods where protein modifications during cooking may affect detectability, requiring specialized testing protocols for heat-treated products.

Wheat and soy allergens benefit from established testing methodologies, though the rise of alternative grain processing creates new contamination pathways that traditional protocols may not adequately address. Fish and shellfish allergens face increasing complexity as aquaculture practices diversify and processing facilities handle multiple species simultaneously. The "Others" category encompasses emerging allergens like mustard and celery that lack standardized testing protocols, creating market opportunities for specialized testing service providers. Aptamer-based detection systems, such as AYA22AR321 for peanut allergens, demonstrate potential for enhanced specificity and reduced cross-reactivity compared to traditional antibody-based methods

Immunoassay/ELISA technology maintains market leadership with 45.85% share in 2025, supported by established validation protocols, cost-effectiveness, and widespread laboratory familiarity that enables rapid implementation across diverse testing environments. Next-generation sequencing represents the fastest-growing segment at 6.55% CAGR through 2031, driven by its ability to simultaneously detect multiple allergens and provide definitive identification even in highly processed foods where protein structures may be altered. PCR-based methods offer enhanced sensitivity for detecting allergenic DNA sequences, particularly valuable for processed foods where protein-based detection may fail due to thermal degradation or chemical modification. Lateral-flow and biosensor technologies gain traction for point-of-use applications, enabling real-time testing in production environments though sensitivity limitations restrict their use to screening applications.

LC-MS/HPLC-MS systems provide superior specificity for complex food matrices, with university research demonstrating their effectiveness in analyzing processed foods' allergenic potential, though high equipment costs limit adoption to larger testing facilities. Other rapid methods, including nanobody-based assays, offer enhanced stability and reduced cross-reactivity compared to traditional antibodies, with research demonstrating effective detection of macadamia, peanut, and milk proteins. The integration of artificial intelligence in testing interpretation, exemplified by AllergenAI's protein sequence analysis capabilities, suggests future automation potential though regulatory acceptance remains uncertain. Technology selection increasingly depends on food matrix complexity, with highly processed foods requiring more sophisticated analytical approaches than raw ingredients.

Complete Report Scope:

• By Allergen Type
  • Peanuts
  • Tree Nuts
  • Milk
  • Eggs
  • Wheat
  • Soy
  • Sesame
  • Fish
  • Shellfish
  • Others
• By Technology
  • Immunoassay/ELISA
  • PCR
  • Lateral-flow and Biosensors
  • LC-MS/HPLC-MS
  • Next-Generation Sequencing (NGS)
  • Other Rapid Methods
• By Food Tested
  • Dairy Products
  • Bakery and Confectionery
  • Meat and Seafood
  • Baby Food and Infant Formula
  • Beverages
  • Plant-based/Novel Proteins
  • Other Processed Foods
• By Testing Mode
  • Lab Testing
  • Testing Kits
• By Geography
  • Northeast
  • Midwest
  • South
  • West

List of Companies Covered in this Report:

• Eurofins Scientific
• SGS Societe Generale de Surveillance SA.
• BeaconPoint Labs, LLC
• Certified Group
• Institut Merieux (Merieux NutriSciences Corporation)
• TUV SUD AG
• R-Biopharm AG
• Neogen Corporation
• DSM-Firmenich AG (Romer Labs Division Holding)
• AGQ Labs
• EW Group (Hygiena LLC)
• Microbac Laboratories
• IEH Laboratories and Consulting Group
• ALS Global
• Anresco Laboratories
• General Mills Inc. (Medallion Labs)
• Bia Diagnostics
• Biogen Laboratory Developments, LLC
• Thermo Fisher Scientific Inc.
• Deibel Laboratories

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support